These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Liquid chromatography-tandem mass spectrometric method for determination of E121 in mouse plasma and its application to pharmacokinetics. Matar KM, El-Hashim AZ, Edafiogho IO. J Sep Sci; 2010 Jul; 33(13):1888-96. PubMed ID: 20533338 [Abstract] [Full Text] [Related]
7. Pharmacokinetics and brain uptake of AM-36, a novel neuroprotective agent, following intravenous administration to rats. Nicolazzo JA, Nguyen TT, Katneni K, Steuten JA, Smith G, Jarrott B, Callaway JK, Charman SA. J Pharm Pharmacol; 2008 Feb; 60(2):171-8. PubMed ID: 18237464 [Abstract] [Full Text] [Related]
8. A liquid chromatography-mass spectrometry assay for simultaneous determination of two antimalarial thiazolium compounds in human and rat matrices. Taudon N, Margout D, Calas M, Kezutyte T, Vial HJ, Bressolle FM. J Pharm Biomed Anal; 2008 Nov 04; 48(3):1001-5. PubMed ID: 18678456 [Abstract] [Full Text] [Related]
10. Pharmacokinetic study of p-chloronitrobenzene in rat. Yoshida T. Drug Metab Dispos; 1994 Nov 04; 22(2):275-80. PubMed ID: 8013283 [Abstract] [Full Text] [Related]
11. Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans. Martin SW, Bishop FE, Kerr BM, Moor M, Moore M, Sheffels P, Rashed M, Slatter JG, Berthon-Cédille L, Lepage F, Descombe JJ, Picard M, Baillie TA, Levy RH. Drug Metab Dispos; 1997 Jan 04; 25(1):40-6. PubMed ID: 9010628 [Abstract] [Full Text] [Related]
12. Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats. Song P, Ma F, Wang F, Wang X, Patil R, Ramagiri S, Orr WE, Miller DD, Geisert E, Yates CR. Cancer Chemother Pharmacol; 2008 May 04; 61(6):1037-44. PubMed ID: 17768626 [Abstract] [Full Text] [Related]
16. Effect of P-glycoprotein on the pharmacokinetics and tissue distribution of enaminone anticonvulsants: analysis by population and physiological approaches. Cox DS, Scott KR, Gao H, Eddington ND. J Pharmacol Exp Ther; 2002 Sep 04; 302(3):1096-104. PubMed ID: 12183668 [Abstract] [Full Text] [Related]
17. Oral and i.v. pharmacokinetics of isosteviol in rats as assessed by a new sensitive LC-MS/MS method. Jin H, Gerber JP, Wang J, Ji M, Davey AK. J Pharm Biomed Anal; 2008 Nov 04; 48(3):986-90. PubMed ID: 18701231 [Abstract] [Full Text] [Related]
18. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D, Wang L, Raghavan N, Zhang H, Li W, Cheng PT, Yao M, Zhang L, Zhu M, Bonacorsi S, Yeola S, Mitroka J, Hariharan N, Hosagrahara V, Chandrasena G, Shyu WC, Humphreys WG. Drug Metab Dispos; 2007 Jan 04; 35(1):150-67. PubMed ID: 17062777 [Abstract] [Full Text] [Related]
19. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582. Fagerholm U, Breuer O, Swedmark S, Hoogstraate J. J Pharm Pharmacol; 2005 May 04; 57(5):587-97. PubMed ID: 15901348 [Abstract] [Full Text] [Related]
20. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E, Cloyd J, Critchley D, Fuseau E. Epilepsia; 2008 Jul 04; 49(7):1123-41. PubMed ID: 18503564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]